Characteristics and mortality of severe influenza cases treated with parenteral aqueous zanamivir, United Kingdom, October 2009 to January 2011

BACKGROUND: Aqueous zanamivir solution, an investigational product, was provided by the manufacturer on compassionate grounds for parenteral administration to severe H1N1pdm09 influenza cases during the 2009 pandemic. OBJECTIVE: To describe characteristics and outcomes of UK patients receiving paren...

Descripción completa

Detalles Bibliográficos
Autores principales: Cleary, Paul Robert, Crofts, Jonathan, Parry‐Ford, Frances, Chand, Meera, Phin, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304314/
https://www.ncbi.nlm.nih.gov/pubmed/30137684
http://dx.doi.org/10.1111/irv.12603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304314/
https://www.ncbi.nlm.nih.gov/pubmed/30137684
http://dx.doi.org/10.1111/irv.12603

Ejemplares similares